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Abstract
 
COVID-19 has quickly spread across the globe, becoming a pandemic. This disease has a 
variable impact in different countries depending on their cultural norms, mitigation efforts and 
health infrastructure. In India, a majority of people rely upon traditional Indian medicine to treat 
human maladies due to less-cost, easier availability and without any side-effect. These medicines 
are made by herbal plants. This study aims to assess the Indian herbal plants in the pursuit of 
potential COVID-19 inhibitors using in silico approaches. We have considered 18 extracted 
compounds of 11 different species of these plants. Our calculated lipophilicity, aqueous 
solubility and binding affinity of the extracted compounds suggest that the inhibition potentials 
in the order; harsingar > aloe vera > giloy > turmeric > neem > ashwagandha > red onion > tulsi 
> cannabis > black pepper. On comparing the binding affinity with hydroxychloroquine, we note 
that the inhibition potentials of the extracts of harsingar, aloe vera and giloy are very promising. 
Therefore, we believe that these findings will open further possibilities and accelerate the works 
towards finding an antidote for this malady. 
Keywords: COVID-19; Inhibitors; Indian Herbal Plants; Natural Extracts; Molecular Docking. 
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Introduction 
The coronavirus disease (COVID-19) has been declared as a worldwide epidemic by the 
world health organization (WHO). According to the latest update of the WHO
1
, there are more 
than 1 million cases of the COVID-19 worldwide, causing almost 50 thousand deaths affecting 
203 countries, areas or territories. This novel coronavirus was detected in late December 2019 
and recognized in early January 2020 in China
2,3
. On 11 February 2020, the international 
committee on taxonomy of viruses declared this “severe acute respiratory syndrome coronavirus 
2” (SARS-CoV-2) as the new virus4. Presumably, this virus picks up its name from the virus 
responsible for the SARS outbreak of 2003 as they are genetically related but different. 
Subsequently, the WHO announced “COVID-19” as the name of this new disease5. The COVID-
19 spread abruptly across the globe, becoming a pandemic within a couple of weeks and apart 
from China, the news of the carnage started pouring in from countries like the USA, Italy, Spain, 
France, Germany and Iran along with India on a day to day basis. After the first case of the 
COVID-19 on 30 January 2020 in India, there become 1466 cases and 38 deaths as per official 
data of the ministry of health and family welfare, India
6
.  
Unfortunately, there has been no noticeable breakthrough in the management of this 
disease to date and the patient is given a treatment based on his observable and diagnosable 
symptoms. Although several attempts have been made in the research and development of the 
diagnostics, therapeutics and vaccines for this novel coronavirus
7
, there exists no 
chemotherapeutic agent so far which has been shown unequivocally to be effective in treating 
human diseases due to a minuscule virus. To combat this deadly COVID-19, a number of 
conventional drugs
8-10
 like chloroquine, hydroxychloroquine, remdesivir, etc. have been tried and 
found with certain curative effect in vitro. However, the clinical drug response is not very 
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encouraging and toxicity remains an inevitable issue causing serious adverse effects
11
. This 
prompted us to study the inhibition of COVID-19 protease by Indian herbal plants.  
Because of the inherent side effects of the synthetic chemicals used in allopathic drugs, a 
sizeable population has switched over to the traditional system of medicine (herbal medicine) for 
their primary health care. Ayurveda, the age-old Indian system of medicine, is increasingly 
becoming a sought after system to bank on. The ayurvedic treatment has become an alternative 
to conventional medicines due to several reasons including easy availability, less or no side 
effects and less cost. India has always been a rich reservoir of medicinal plants because of 
several agro-climatic zones. Therefore, in the present work, we have chosen a multitude of 
Indian herbal plants such as harsingar (Nyctanthes arbor-tristis), giloy (Tinospora cordifolia), 
aloe vera (Aloe barbadensis miller), turmeric (Curcuma longa), neem (Azadirachta indica), 
ashwagandha (Withania somnifera), ginger (Zingiber officinale), red onion (Allium cepa), tulsi 
(Ocimum sanctum), cannabis (Cannabis sativa) and black pepper (Piper nigrum). The 
pharmacological importance of these plants is well documented in the literature
12-14
. We have 
selected a few extracted compounds of these herbal plants and evaluated their inhibition 
properties against COVID-19 main protease in silico. We have obtained encouraging responses 
from most of these medicinal plants in general. The inhibition potentials of harsingar, aloe vera 
and giloy are particularly interesting. Therefore, we believe that this study should offer some 
insights into the development of alternative drugs for this novel coronavirus.    
Methodology  
This study was performed by the SwissDock web server
15,16
, which incorporates an 
automated in silico molecular docking procedure based on the EADock ESS docking algorithm. 
To determine the inhibition properties of Indian medicinal plants against COVID-19 protease, 
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the potential target protein was retrieved from the RCSB protein data bank (PDB ID: 6LU7) 
deposited in February 2020
17
. The processed coordinates files for the ligands as well as COVID-
19 protease (6LU7) has been uploaded, and docking was carried out with the „Accurate‟ 
parameter option, which is considered to be the most extensive for the sampling of the binding 
modes. The output clusters have been obtained after each docking runs and classified based on 
the full fitness (FF) score by the SwissDock algorithm. A greater negative FF score suggests a 
more favorable binding mode between ligand and receptor with a better fit. The visual graphics 
of docking results have been generated by using the UCSF Chimera program
18
. 
In addition, we have calculated the lipophilicity (log P) and aqueous solubility (log S) 
using ALOGPS 2.1 program
19
, which is based on the electro-topological state indices and 
associative neural network modeling
20
. These two parameters are very important for quantitative 
structure-property relationship (QSPR) studies.   
Results and Discussion 
We have considered a total of 11 different varieties (species) of Indian medicinal plants. 
Fig. 1 displays the molecular structures of a few (main) compounds extracted from these plants. 
We have focused on mainly those compounds which have been found to possess anti-malarial, 
anti-viral or other similar activities. Nictoflorin (C27H30O15), astragalin (C21H20O11), lupeol 
(C25H26O4) are extracted from the leaves of harsingar. Berberine (C28H18NO4) and sitosterol 
(C29H50O) are chemical constituents of the stem of the giloy. Aloenin (C19H22O10) and aloesin 
(C19H22O9) are extracted from aloe vera leaves.
 
Curcumin (C21H20O6) is extracted from the dried 
ground rhizome of the turmeric. Nimbin (C30H36O9) is the first bitter compound isolated from the 
oil of neem. Withanolide (C28H38O6) and withaferin A (C28H38O6) are steroidal constituents of 
ashwagandha.  
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Fig. 1. Molecular structures of the compounds extracted from Indian herbal plants. Harsingar 
(night jasmine or parijat) is distributed widely in sub-Himalayan regions, southwards to 
Godavari and also found in Indian gardens as ornamental plant. Giloy (moonseed plant or 
guduchi) is a large deciduous, extensively spreading climbing shrub found throughout India and 
also in Bangladesh, Srilanka and China. Aloe vera (ghrit kumari) is a well known medicinal 
plant with sharp pointed, lanced shaped and edged leaves having its origin in African content, 
Turmeric (circumin or haldi), a traditional Chinese medicine, is commonly used species in Indian 
subcontinent, not only for health but also for the preservation of food. Ashwagandha is known as 
Indian winter cherry. Neem (margosa tree) also called as Indian lilac with its centre of origin in 
southern and southeastern Asia, is regarded as „village dispensary‟ in India and also a religious 
gift from nature. Red onion is a versatile vegetable, i.e., consumed fresh as well as in the form of 
processed products. Tulsi is the one of the most religious and medicinal plant in India and grown 
throughout the country from Andaman and Nicobar island to the Himalayas. Cannabis is a plant 
of psychoactive drug and black pepper is a kind of household species used in India.  
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Gingerol (C17H26O4) and shogaol (C17H24O3) are two constituents of pungent ketones, 
which result in the strong aroma of ginger. Quercetin (C15H10O7) is the main flavonoid content of 
(red) onion. Ursolic acid (C30H48O3) and apigenin (C15H10O5) are chemical constituents of tulsi 
leaves. Cannabidiol (C21H30O2) major constituent of cannabis extracts and is devoid of the 
typical psychological effects of cannabis in humans. Piperine (C17H19NO3) is a naturally 
occurring alkaloid, was isolated from the plants of both the black and white pepper grains.  
In order to compare the biological activity and pharmacological behavior of the extracted 
compounds, we have evaluated their log P as well as log S values and listed in Table 1. Log P 
measures the hydrophilicity of a compound. The compounds having high log P values show poor 
absorption or low permeability. One can note that the log P values of most of these compounds 
lie in the range 2.64-4.95. These values indicate that the compounds can easily diffuse across the 
cell membranes due to their high organic (lipid) permeability. However, lupeol, sitosterol, ursolic 
acid and cannabidiol have log P in the range 5.12-7.27 (exceeding to 5) and therefore, they 
possess high hydrophobicity and poor absorption. On the contrary, nictoflorin, astragalin, 
aloenin, aloesin and quercetin possess high absorption due to their log P in the range 0.05-1.81. 
Log S represents the aqueous solubility of the compound. It is an important factor, associated 
with the bioavailability of compounds. Most of these compounds have log S values higher than -
5, except lupeol, sitosterol and ursolic acid. Note that the log S values of more than 85% of 
compounds (drugs) fall in the range between -1 and -5 
21
. This is consistent with their log P 
values as poor solubility implies poor absorption and hence, bioavailability. Thus, log P along 
with log S values of these compounds confirmed their permeability across cell membranes. In 
particular, the nictoflorin, astragalin, aloenin, aloesin and quercetin seem to be more biologically 
potent. These parameters are also associated with their interaction with receptors. 
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Table 1. Calculated parameters of compounds extracted from Indian herbal plants as possible 
inhibitors of COVID-19 protease.  
 
Indian herbal 
plants 
Extracted 
compounds 
Log 
P 
Log 
S 
Binding 
affinity 
(kcal/mol) 
FF 
score 
Active sites/Binding 
residue/ H-bond length 
(Å) 
Harsingar Nictoflorin 
(C27H30O15) 
0.07 -2.29 -9.18 -1057 N-H--O/GLY-143/2.311 
Astragalin 
(C21H20O11) 
0.52 -2.45 -8.68 -1123 O--H/PHE-140/2.197 
Lupeol 
(C25H26O4) 
5.12 -5.26 -8.28 -1160 N-H--O/THR-26/2.027 
Aloe vera Aloenin 
(C19H22O10) 
0.05 -2.35 -9.13 -1120 O--H/PHE-140/2.151 
Aloesin 
(C19H22O9) 
0.12 -1.99 -8.79 -1135 N-H--O/GLY-143/2.016 
N-H--O/GLU-166/2.297 
Giloy Berberine 
(C28H18NO4) 
3.75 -4.16 -8.67 -1168 N-H--O/GLY-143/2.540 
N-H--O/GLY-143/2.577 
Sitosterol 
(C29H50O) 
7.27 -7.35 -8.42 -1178 O--H/PHE-166/2.080 
Turmeric Curcumin 
(C21H20O6) 
3.62 -4.81 -8.44 -1196 N-H--O/GLY-143/2.243 
Neem Nimbin 
(C30H36O9) 
3.71 -4.36 -8.17 -1128 N-H--O/GLY-143/2.161 
Ashwagandha 
 
Withanolide 
(C28H38O6) 
2.70 -4.91 -8.07   -915 O--H/GLU-166/1.991 
N-H--O/GLU-166/2.110 
Withaferin A 
(C28H38O6) 
2.64 -4.81 -8.05 -942 N-H--O/GLY-143/2.577 
Ginger Gingerol 
(C17H26O4) 
3.45 -3.57 -7.95 -1220 O--H/THR-190/2.026 
Shogaol 
(C17H24O3) 
4.95 -4.49 -7.86 -1209 N-H--O/GLY-143/2.289 
N-H--O/THR-26/2.398 
O--H/THR-24/2.345 
Red Onion Quercetin 
(C15H10O7) 
1.81 -3.06 -7.70 -1189 O--H/THR-26/1.936 
 
Tulsi Ursolic acid 
(C30H48O3) 
6.35 -5.89 -7.46 -1152 N-H--O/GLY-143/2.330 
 
Apigenin 
(C15H10O5) 
3.07 -3.36 -7.38 -1210 O--H/THR-26/1.994 
Cannabis  Cannabidiol 
(C21H30O2) 
6.10 -4.40 -7.10 -1214 N-H--O/GLY-143/2.325 
 
Black Pepper Piperine 
(C17H19NO3) 
3.38 -3.28 -6.98 -1211 N-H--O/THR-26/2.529 
 
 
9 
 
The molecular docking studies explore the interaction mechanism between ligands and 
receptors. The interactions between a ligand and receptor play a crucial role in the field of drug 
discovery. The molecular docking calculations have been performed as blind, i.e., covered the 
entire protein surface, not any specific region of the protein as the binding pocket in order to 
avoid sampling bias. The docking parameters such as binding affinity, FF score, and H-bond, 
bond-length along with amino acids (residue) found in the binding site pockets (active site) of 
6LU7 are listed in Table 1. The results of molecular docking are displayed in Fig. 2.   
The binding affinity (∆G) of (drug) compounds depends on the type of bonding (H-bond) 
that occurs with the active site of the protein. The results of docking show that the extracts of 
harsingar, nictoflorin, astragalin and lupeol form H-bond of bond lengths 2.311 Å, 2.197 Å and 
2.027 Å with the glycine (GLY-143), phenylalanine (PHE-140) and threonine (THR-26) 
respectively. The compounds of aloe vera, aloenin forms H-bond (bond length = 2.151 Å) with 
phenylalanine (PHE-140) and aloesin forms two H-bonds with GLY-143 (bond length = 2.016 
Å) and glutamate (GLU-166) with bond length = 2.297 Å. The constituents of giloy, berberine 
forms two H-bonds with the same amino acid GLY-143 having bond lengths of 2.540 Å and 
2.577 Å, whereas sitosterol forms H-bond with PHE-166 of bond length 2.080 Å. The 
compounds of turmeric and neem, curcumin and nimbin form H-bonds with the same amino acid 
GLY-143 of bond lengths 2.243 Å and 2.161 Å, respectively. The derivatives of ashwagandha, 
withanolide forms two H-bonds with the GLU-166 (bond length = 1.991 Å and 2.110 Å) and 
withaferin A forms H-bond with GLY-143 of bond length 2.577 Å. The compounds of ginger, 
gingerol forms H-bond with THR-190 (bond length = 2.026 Å) and shogaol forms three H-
bonds, one with GLY-143 (bond length = 2.016 Å) and two with the THR-26 and THR-24 
having bond lengths 2.398 Å and 2.345 Å, respectively.  
10 
 
 
Fig. 2. The binding of COVID-19 protease (6LU7) receptor with the extracts of Indian herbal 
plants explored by molecular docking. 
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The derivatives of red onion and black pepper, quercetin and piperine form H-bond with 
the THR-26 of bond lengths 2.243 Å and 2.161 Å, respectively. The extracts of tulsi, ursolic acid 
and apigenin form H-bonds with the GLY-143 (bond length = 2.330 Å) and the THR-26 (bond 
length = 1.994 Å), respectively. The constituent of cannabis, cannabidiol forms H-bond with the 
GLY-143 (bond length = 2.325 Å), a non-polar amino acid.  
 
Fig. 3. Binding affinity plot of Indian herbal plants and a few drugs for comparison of inhibition 
potential against COVID-19 protease.   
 
Thus, our docking analyses suggest that the COVID-19 protease (6LU7) can be inhibited 
by the extracts of Indian herbal plants. Based on the binding affinity, the inhibition potential of 
these plants (based on their extracts) can be ranked as; harsingar > aloe vera > giloy > turmeric > 
neem > ashwagandha > red onion > tulsi > cannabis > black pepper. The highest inhibition 
potentials are obtained for the extracts of harsingar and aloe vera, namely nictoflorin (∆G = -
12 
 
9.18) and aloenin (∆G = -9.13), respectively. This also provides us an opportunity to compare the 
∆G value of the compounds extracted from other plants. Fig. 3 plots the binding affinities of 
these compounds, along with those of a few previously reported inhibitors such as remdesivir, 
chloroquine and hydroxychloroquine. Considering hydroxychloroquine as a reference, we note 
that the inhibition potentials of the extracts of harsingar, aloe vera and giloy are very 
encouraging. The extracts of turmeric, neem, ashwagandha and ginger have larger inhibition 
potentials than that of chloroquine. The compounds extracted from other plants also possess 
certain inhibition properties against COVID-19 protease. 
Conclusions and Perspectives  
We have performed an in silico study on the inhibition of COVID-19 protease by the 
extracts of Indian herbal plants. We noticed that all these plants possess inhibition properties to a 
certain extent. Based on the binding affinity as well as log P and log S values, harsingar, aloe 
vera and giloy appear as the most powerful inhibitors among the eleven plants considered here. 
Other potential inhibitors of COVID-19 protease include turmeric, neem, ashwagandha and 
ginger. The inhibition potentials of all these plant extracts are found to be larger than those of 
chloroquine and hydroxychloroquine. These two anti-malarial drug compounds are already 
reported to inhibit COVID-19 protease in vitro. Due to inherent toxicity and side-effects, 
however, they are not approved by most of the countries. Therefore, our findings become very 
interesting towards the development of alternative (herbal) medicines having no apparent side-
effects. We expect prompt actions in this direction to combat with the COVID-19.  
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